A Short-Term, Multicenter, Placebo-Controlled, Randomized Withdrawal Study of a Metabotropic Glutamate 2/3 Receptor Agonist Using an Electronic Patient-Reported Outcome Device in Patients With Schizophrenia

This 6-week, multicenter, randomized withdrawal, placebo-controlled trial sought to determine whether symptoms of physical dependence occur after abrupt cessation of pomaglumetad methionil (LY2140023 monohydrate), a metabotropic glutamate 2/3 receptor agonist, in patients with schizophrenia. Eligibl...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Stauffer, Virginia L., Baygani, Simin K., Kinon, Bruce J., Krikke-Workel, Judith O.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Lippincott Williams & Wilkins 2014
Ämnen:
Original Contributions
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4165473/
https://ncbi.nlm.nih.gov/pubmed/25006819
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JCP.0000000000000187
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk